#1 Clinical Trials Search in Europe

Bleomycin Sulfate Ph. Eur.

This article discusses two clinical trials investigating the use of Bleomycin Sulfate Ph. Eur., a medication primarily used in cancer treatment. The first trial examines the effects of various cancer treatments, including Bleomycin, on speech perception, cognition, and quality of life in patients with different types of cancer. The second trial focuses on using Bleomycin in sclerotherapy for treating Warthin’s tumor, a benign salivary gland tumor. These studies aim to improve our understanding of Bleomycin’s efficacy and potential side effects in different medical contexts.

Table of Contents

What is Bleomycin Sulfate?

Bleomycin Sulfate, also known by its brand name Bleomycin Baxter, is a powerful medication used in the treatment of various types of cancer[1]. It belongs to a class of drugs called antineoplastics or anti-cancer medications. Bleomycin works by interfering with the DNA in cancer cells, which helps to slow or stop their growth[1].

Medical Uses of Bleomycin Sulfate

Bleomycin Sulfate is primarily used in the treatment of several types of cancer, including:

  • Testicular cancer: Both seminoma (a type of testicular cancer that develops in sperm-producing cells) and non-seminoma testicular cancer[1]
  • Head and neck cancer: Various types of cancers affecting the head and neck region[1]
  • Gastrointestinal tract cancer: Cancers affecting the digestive system[1]

In addition to its use in cancer treatment, recent research is exploring the potential of Bleomycin Sulfate in treating non-cancerous conditions. One such application is in the treatment of Warthin’s tumor, a benign tumor of the salivary glands[2].

How is Bleomycin Sulfate Administered?

Bleomycin Sulfate is typically administered in two main ways:

  1. Intravenous infusion: This means the medication is given directly into a vein. It’s the most common method for cancer treatment[1].
  2. Intralesional use: In some cases, such as in the treatment of Warthin’s tumor, the medication may be injected directly into the affected area. This method is known as sclerotherapy[2].

The method of administration will depend on the specific condition being treated and will be determined by your healthcare provider.

Dosage Information

The dosage of Bleomycin Sulfate can vary depending on the condition being treated, the patient’s body weight, and other factors. However, some general guidelines include:

  • For cancer treatment, the maximum daily dose is typically around 30,000 IU (International Units)[1].
  • The maximum total dose over a treatment course (usually about 12 weeks) is generally not more than 360,000 IU[1].
  • For non-cancer treatments like Warthin’s tumor, the dosage is usually much lower, around 15,000 IU as a single dose[2].

It’s crucial to note that these are general guidelines, and your actual dosage will be determined by your healthcare provider based on your specific needs and condition.

Potential Side Effects and Precautions

Like all medications, Bleomycin Sulfate can cause side effects. Some potential side effects include:

  • Lung-related issues: Bleomycin can affect lung function, so patients with existing lung conditions need to be monitored closely[2].
  • Kidney function: The medication is processed by the kidneys, so patients with kidney problems may need dose adjustments[2].
  • Fertility: Bleomycin may affect fertility, so patients planning to have children should discuss this with their doctor[2].

Your healthcare provider will discuss all potential side effects and precautions with you before starting treatment.

Ongoing Research and Clinical Trials

Researchers are continually studying Bleomycin Sulfate to understand its effects better and explore new potential uses. Some ongoing research includes:

  • A study on the effects of cancer treatments, including Bleomycin, on speech perception, cognition, and quality of life[1].
  • Research on using Bleomycin for sclerotherapy (a minimally invasive treatment) in Warthin’s tumor, as an alternative to surgery[2].

These studies aim to improve our understanding of how Bleomycin affects patients in the short and long term, potentially leading to better treatment strategies in the future.

Aspect Trial 1: Cancer Treatment Effects Trial 2: Warthin’s Tumor Treatment
Main Objective Assess short-term effects of cancer treatments on speech perception in noise Examine efficacy and safety of Bleomycin sclerotherapy for Warthin’s tumor
Bleomycin Use Part of cancer treatment regimen Used in sclerotherapy
Key Inclusion Criteria Cancer diagnosis, age-normative hearing, native Finnish speaker Warthin’s tumor diagnosis, ≥18 years old, adequate kidney function
Primary Endpoint Change in speech perception in noise at 3-4 months post-treatment Volume and symptom change at 6 and 12 months post-treatment
Bleomycin Dosage Max daily dose: 30,000 IU, Max total dose: 360,000 IU Max daily and total dose: 15,000 IU

FAQ

  • What is Bleomycin Sulfate Ph. Eur. used for in these clinical trials? In the first trial, Bleomycin Sulfate Ph. Eur. is used as part of cancer treatment for various types of cancer, including testicular and head and neck cancers. In the second trial, it is used for sclerotherapy to treat Warthin's tumor, a benign salivary gland tumor.
  • What are the main objectives of the first clinical trial? The main objective of the first trial is to assess the short-term effect of different cancer treatments, including Bleomycin, on speech perception in noise. Secondary objectives include investigating long-term effects on speech perception, high-frequency hearing, hearing-related quality of life, and cognitive function.
  • Who can participate in the first clinical trial? Participants in the first trial must have a cancer diagnosis that will be treated with curative intent, have age-normative hearing, be able to provide written informed consent, and be native Finnish speakers. Exclusion criteria include major otological conditions, severe hearing loss, and prior use of ototoxic medication.
  • What is the purpose of the second clinical trial? The second clinical trial aims to examine the efficacy and safety of ultrasound-guided Bleomycin sclerotherapy for treating Warthin's tumor, a benign tumor of the salivary glands.
  • What are the key inclusion criteria for the second clinical trial? Key inclusion criteria for the second trial include having a Warthin's tumor diagnosed by FNAB/CNAB, MRI, and clinical examination, being at least 18 years old, having adequate kidney function, and the tumor being located in the parotid gland. Patients must also prefer non-surgical intervention.

Ongoing Clinical Trials on Bleomycin Sulfate Ph. Eur.

  • Study on the Impact of Cisplatin and Drug Combination on Speech and Cognition in Cancer Patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • A study to evaluate the effectiveness of bleomycin sulfate for treating patients with low-flow vascular malformations using electrosclerotherapy.

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Slovenia

  • Study on the Treatment of Warthin’s Tumor with Bleomycin Sclerotherapy for Patients with Warthin’s Tumor

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

Glossary

  • Bleomycin Sulfate Ph. Eur.: A medication used in cancer treatment and, in these trials, for treating Warthin's tumor. It belongs to a class of drugs called antineoplastics and works by damaging the DNA of cancer cells.
  • Sclerotherapy: A medical procedure used to treat various conditions by injecting a solution directly into blood vessels or tissues to cause them to shrink or collapse.
  • Warthin's tumor: A benign tumor that typically occurs in the salivary glands, most commonly in the parotid gland.
  • Speech perception in noise: The ability to understand speech in the presence of background noise, which can be affected by certain medical treatments.
  • FNAB/CNAB: Fine Needle Aspiration Biopsy or Core Needle Aspiration Biopsy, procedures used to obtain tissue samples for diagnosis.
  • MRI: Magnetic Resonance Imaging, a medical imaging technique used to create detailed images of the body's internal structures.
  • Ototoxic: Referring to substances that can damage the ear, potentially causing hearing loss or balance problems.
  • GFR: Glomerular Filtration Rate, a measure of kidney function used to assess eligibility for certain treatments.

References

  1. http://clinicaltrials.eu/trial-id/2024-513437-21-00
  2. http://clinicaltrials.eu/trial/study-on-the-treatment-of-warthins-tumor-with-bleomycin-sclerotherapy-for-patients-with-warthins-tumor/